RxDoctor Payments Data

David Pace, APRN

Family · Hazard, KYNPI 1114630746

Payments from drug & device makers

$609in general payments, 2019–2025

Across 31 payments — averaging $19.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$160
  • AstraZeneca$126
  • Boehringer Ingelheim$73
  • Pfizer$68
  • Johnson & Johnson$42
  • Lilly USA, LLC$32
  • plus $108 from 6 others

What the payments were for

  • Food & beverage$609100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$609 in reported general payments places this provider in the 55th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$3,322
Medicare patients
81
Services billed
251

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol30$22,687
TrulicityDulaglutide21$19,342
JardianceEmpagliflozin17$14,508
Combivent RespimatIpratropium/Albuterol Sulfate14$7,694
Lantus SolostarInsulin Glargine,hum.Rec.Anlog18$1,942
Albuterol Sulfate HfaAlbuterol Sulfate49$1,665
Nebivolol Hcl26$1,117
Cefdinir86$862
Fluconazole134$742
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav80$598
Levothyroxine Sodium46$525
Ofloxacin15$403
Metoprolol Succinate26$371
Potassium Chloride31$339
Prednisone66$286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$126$22,68730 claims
Boehringer IngelheimJardiance, Combivent Respimat$73$22,20231 claims
Lilly USA, LLCTrulicity$32$19,34221 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,374 family providers in Kentucky.

Other family in Hazard

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →